How to balance risks and benefits in the management of CKD patients with coronary artery disease

[1]  F. Veglia,et al.  Post‐procedural hemodiafiltration in acute coronary syndrome patients with associated renal and cardiac dysfunction undergoing urgent and emergency coronary angiography , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  J. Tu,et al.  Clinical Outcomes of Treatment by Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Patients With Chronic Kidney Disease Undergoing Index Revascularization in Ontario , 2014, Circulation. Cardiovascular interventions.

[3]  Helmut Baumgartner,et al.  2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[4]  H. Nasri,et al.  Contrast-induced nephropathy; A literature review. , 2014, Journal of nephropathology.

[5]  H. Gurm,et al.  Risk of Acute Kidney Injury After Percutaneous Coronary Interventions Using Radial Versus Femoral Vascular Access: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium , 2014, Circulation. Cardiovascular interventions.

[6]  C. Trani,et al.  Randomized Comparison of Xience V and Multi-Link Vision Coronary Stents in the Same Multivessel Patient With Chronic Kidney Disease (RENAL-DES) Study , 2014, Circulation.

[7]  R. Hermosilla,et al.  Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4 , 2014, Clinical kidney journal.

[8]  S. de Servi,et al.  Continuous venovenous hemofiltration after coronary procedures for the prevention of contrast-induced acute kidney injury in patients with severe chronic renal failure. , 2014, The American journal of cardiology.

[9]  C. Vassanelli,et al.  Drug-eluting stent or coronary artery bypass graft surgery in hemodialysis patients? , 2014, Journal of Nephrology.

[10]  H. Miyata,et al.  Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention. , 2013, Journal of the American College of Cardiology.

[11]  F. Veglia,et al.  Incidence and relevance of acute kidney injury in patients hospitalized with acute coronary syndromes. , 2013, The American journal of cardiology.

[12]  Ri-tai Huang,et al.  Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention in patients with end-stage renal disease. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  L. Menicanti,et al.  Acute kidney injury in patients undergoing cardiac surgery and coronary angiography on the same day. , 2013, The Annals of thoracic surgery.

[14]  D. Cruz.  Cardiorenal syndrome in critical care: the acute cardiorenal and renocardiac syndromes. , 2013, Advances in chronic kidney disease.

[15]  C. Herzog,et al.  Risks of Death and End-Stage Renal Disease After Surgical Compared With Percutaneous Coronary Revascularization in Elderly Patients With Chronic Kidney Disease , 2012, Circulation.

[16]  M. Leoncini,et al.  Persistent Renal Damage After Contrast-Induced Acute Kidney Injury: Incidence, Evolution, Risk Factors, and Prognosis , 2012, Circulation.

[17]  Maegan S. Reynolds.  Chronic Kidney Disease and Risk for Presenting with Acute Myocardial Infarction versus Stable Exertional Angina in Adults with Coronary Heart Disease , 2012 .

[18]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[19]  F. Veglia,et al.  Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. , 2012, JACC. Cardiovascular interventions.

[20]  A. Renzulli,et al.  Acute kidney injury: a relevant complication after cardiac surgery. , 2011, Annals of Thoracic Surgery.

[21]  M. Valgimigli,et al.  Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in High-Risk Patients for Contrast-Induced Acute Kidney Injury , 2011, Circulation.

[22]  Ju Han Kim,et al.  Management of non-ST-segment elevation acute myocardial infarction in patients with chronic kidney disease (from the Korea Acute Myocardial Infarction Registry). , 2011, The American journal of cardiology.

[23]  Sunil V. Rao,et al.  Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial , 2011, The Lancet.

[24]  M. Tonelli,et al.  Associations Between Acute Kidney Injury and Cardiovascular and Renal Outcomes After Coronary Angiography , 2011, Circulation.

[25]  D. Mukherjee,et al.  Drug‐eluting stents in patients with end‐stage renal disease: Meta‐analysis and systematic review of the literature , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[26]  C. Herzog,et al.  CABG in CKD: untangling the letters of risk. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  M. Keltai,et al.  Coronary Heart Disease Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial , 2010 .

[28]  G. Prescott,et al.  Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. , 2010, Health technology assessment.

[29]  Antonio Colombo,et al.  5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. , 2010, Journal of the American College of Cardiology.

[30]  Chi‐Hang Lee,et al.  Reperfusion strategy and mortality in ST-elevation myocardial infarction among patients with and without impaired renal function. , 2010, Annals of the Academy of Medicine, Singapore.

[31]  K. Alexander,et al.  Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease: A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network R , 2010, Circulation.

[32]  J. Spertus,et al.  Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease. , 2009, The American journal of cardiology.

[33]  David Dai,et al.  Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. , 2009, JAMA.

[34]  L. Wallentin,et al.  Influence of Renal Function on the Effects of Early Revascularization in Non–ST-Elevation Myocardial Infarction: Data From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2009, Circulation.

[35]  A. Iskandrian,et al.  The scope of coronary heart disease in patients with chronic kidney disease. , 2009, Journal of the American College of Cardiology.

[36]  E. Braunwald,et al.  Early angiography in patients with chronic kidney disease: a collaborative systematic review. , 2009, American Society of Nephrology. Clinical Journal.

[37]  J. Schold,et al.  Acute Kidney Injury Is Associated With Increased Long-Term Mortality After Cardiothoracic Surgery , 2009, Circulation.

[38]  A. Garg,et al.  Optimal method of coronary revascularization in patients receiving dialysis: systematic review. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[39]  M. Pencina,et al.  In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. , 2009, JACC. Cardiovascular interventions.

[40]  A. Budaj,et al.  Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events). , 2009, JACC. Cardiovascular interventions.

[41]  Frederic S. Resnic,et al.  Long-Term Clinical Outcomes After Drug-Eluting and Bare-Metal Stenting in Massachusetts , 2008, Circulation.

[42]  D. Brancaccio,et al.  Low-molecular-weight heparins should be used with caution in patients with chronic kidney disease , 2008, Nature Clinical Practice Nephrology.

[43]  R. Califf,et al.  The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. , 2008, American heart journal.

[44]  B. Kasiske,et al.  Excerpts from the United States Renal Data System 2007 annual data report. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[45]  Hiroshi Takahashi,et al.  Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[46]  I. Komuro,et al.  Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[47]  G. Nakazawa,et al.  Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus‐eluting stents , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[48]  S. Yusuf,et al.  Renal function and outcomes in acute coronary syndrome: impact of clopidogrel , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[49]  W. Laskey,et al.  Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. , 2006, The Journal of invasive cardiology.

[50]  Deepak L. Bhatt,et al.  Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. , 2006, Journal of the American College of Cardiology.

[51]  M. Fine,et al.  Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. , 2006, Journal of the American Society of Nephrology : JASN.

[52]  C. Becker,et al.  Epidemiology and prognostic implications of contrast-induced nephropathy. , 2006, The American journal of cardiology.

[53]  S. Steinhubl,et al.  Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. , 2006, The Journal of invasive cardiology.

[54]  S. Yusuf,et al.  Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes , 2006, Circulation.

[55]  V. Boyko,et al.  Should primary percutaneous coronary intervention be the preferred method of reperfusion therapy for patients with renal failure and ST-elevation acute myocardial infarction? , 2006, The American journal of cardiology.

[56]  P. Aspelin,et al.  Contrast-Induced Nephropathy: A Clinical and Evidence-Based Approach , 2006, Circulation.

[57]  Salim Yusuf,et al.  Comparison of fondaparinux and enoxaparin in acute coronary syndromes. , 2006, The New England journal of medicine.

[58]  M. Okusa,et al.  Acute kidney injury associated with cardiac surgery. , 2005, Clinical journal of the American Society of Nephrology : CJASN.

[59]  K. Alexander,et al.  Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. , 2005, JAMA.

[60]  Joseph V Bonventre,et al.  Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. , 2005, Journal of the American Society of Nephrology : JASN.

[61]  W. Markiewicz,et al.  Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. , 2005, American heart journal.

[62]  I. Iakovou,et al.  Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.

[63]  M. Landray,et al.  First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[64]  S. Arrigain,et al.  A clinical score to predict acute renal failure after cardiac surgery. , 2004, Journal of the American Society of Nephrology : JASN.

[65]  B. Davis,et al.  Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial. , 2004, Journal of the American College of Cardiology.

[66]  B. Hemmelgarn,et al.  Survival After Coronary Revascularization Among Patients With Kidney Disease , 2004, Circulation.

[67]  B. McNeil,et al.  "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. , 2004, Journal of the American Society of Nephrology : JASN.

[68]  R. Giugliano,et al.  The Prognostic Value of Serum Creatinine on Admission in Fibrinolytic-Eligible Patients with Acute Myocardial Infarction , 2003, Journal of Thrombosis and Thrombolysis.

[69]  W Klein,et al.  Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). , 2004, European heart journal.

[70]  E. Antman,et al.  Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. , 2003, Journal of the American College of Cardiology.

[71]  G. Marenzi,et al.  The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. , 2003, The New England journal of medicine.

[72]  C. Herzog.  How to manage the renal patient with coronary heart disease: the agony and the ecstasy of opinion-based medicine. , 2003, Journal of the American Society of Nephrology : JASN.

[73]  S. Borzak,et al.  Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. , 2003, The American journal of cardiology.

[74]  Robert M Califf,et al.  Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. , 2003, Journal of the American Society of Nephrology : JASN.

[75]  J. Gore,et al.  Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE) , 2003, Heart.

[76]  B. Horne,et al.  Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency? , 2003, Journal of the American College of Cardiology.

[77]  A. Levin,et al.  THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Clinical Epidemiology of Cardiovascular Disease in Chronic Kidney Disease Prior to Dialysis , 2003, Seminars in dialysis.

[78]  J. Avorn,et al.  Chronic kidney disease as a risk factor for bleeding complications after coronary artery bypass surgery. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[79]  E. Braunwald,et al.  Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial). , 2002, The American journal of cardiology.

[80]  A. Collins,et al.  Comparative Survival of Dialysis Patients in the United States After Coronary Angioplasty, Coronary Artery Stenting, and Coronary Artery Bypass Surgery and Impact of Diabetes , 2002, Circulation.

[81]  M. Mcclellan,et al.  Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients , 2002, Annals of Internal Medicine.

[82]  R. Califf,et al.  Differential survival after coronary revascularization procedures among patients with renal insufficiency. , 2001, Kidney international.

[83]  G. Helft,et al.  Clinical outcome following coronary angioplasty in dialysis patients: a case–control study in the era of coronary stenting , 2001, Heart.

[84]  F. Ragmin.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999, The Lancet.

[85]  A. Collins,et al.  Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. , 1999, Kidney international.

[86]  L. Wallentin,et al.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999 .

[87]  Z. Massy,et al.  Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[88]  R. Nakamura,et al.  Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[89]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[90]  J. Montastruc,et al.  Delayed elimination of enoxaparine in patients with chronic renal insufficiency , 1991 .

[91]  J. Montastruc,et al.  Delayed elimination of enoxaparin in patients with chronic renal insufficiency. , 1991, Thrombosis research.

[92]  P. Marino,et al.  Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial. , 1989, Journal of the American College of Cardiology.

[93]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[94]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.,et al.  EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[95]  E. Veys,et al.  Letter: HL-A and infective sacroileitis. , 1974, Lancet.